539 related articles for article (PubMed ID: 31025308)
1. Generation of Human Stem Cell-Derived Pancreatic Organoids (POs) for Regenerative Medicine.
Navarro-Tableros V; Gomez Y; Brizzi MF; Camussi G
Adv Exp Med Biol; 2020; 1212():179-220. PubMed ID: 31025308
[TBL] [Abstract][Full Text] [Related]
2. Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells.
Jun Y; Kang AR; Lee JS; Park SJ; Lee DY; Moon SH; Lee SH
Biomaterials; 2014 Jun; 35(17):4815-26. PubMed ID: 24636217
[TBL] [Abstract][Full Text] [Related]
3. Immune Protection of Stem Cell-Derived Islet Cell Therapy for Treating Diabetes.
Tahbaz M; Yoshihara E
Front Endocrinol (Lausanne); 2021; 12():716625. PubMed ID: 34447354
[TBL] [Abstract][Full Text] [Related]
4. Advances in islet encapsulation technologies.
Desai T; Shea LD
Nat Rev Drug Discov; 2017 May; 16(5):338-350. PubMed ID: 28008169
[TBL] [Abstract][Full Text] [Related]
5. Research status and prospect of stem cells in the treatment of diabetes mellitus.
Liu X; Wang Y; Li Y; Pei X
Sci China Life Sci; 2013 Apr; 56(4):306-12. PubMed ID: 23564185
[TBL] [Abstract][Full Text] [Related]
6. Stem cell applications in diabetes.
Noguchi H
J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
[TBL] [Abstract][Full Text] [Related]
7. Generation of pancreatic islet cells from human embryonic stem cells.
Zhang D; Jiang W; Shi Y; Deng H
Sci China C Life Sci; 2009 Jul; 52(7):615-21. PubMed ID: 19641866
[TBL] [Abstract][Full Text] [Related]
8. Integration of nano- and biotechnology for beta-cell and islet transplantation in type-1 diabetes treatment.
Dinnyes A; Schnur A; Muenthaisong S; Bartenstein P; Burcez CT; Burton N; Cyran C; Gianello P; Kemter E; Nemeth G; Nicotra F; Prepost E; Qiu Y; Russo L; Wirth A; Wolf E; Ziegler S; Kobolak J
Cell Prolif; 2020 May; 53(5):e12785. PubMed ID: 32339373
[TBL] [Abstract][Full Text] [Related]
9. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
Dadheech N; James Shapiro AM
Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Bioluminescence for the Detection of the Fate of Pancreatic Islet Organoids Post-transplantation.
Sun A; Kenyon E; Gudi M; Li W; Aguirre A; Wang P
Methods Mol Biol; 2023; 2592():195-206. PubMed ID: 36507995
[TBL] [Abstract][Full Text] [Related]
11. Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes.
Lebreton F; Lavallard V; Bellofatto K; Bonnet R; Wassmer CH; Perez L; Kalandadze V; Follenzi A; Boulvain M; Kerr-Conte J; Goodman DJ; Bosco D; Berney T; Berishvili E
Nat Commun; 2019 Oct; 10(1):4491. PubMed ID: 31582751
[TBL] [Abstract][Full Text] [Related]
12. Cell differentiation: therapeutical challenges in diabetes.
Roche E; Vicente-Salar N; Arribas M; Paredes B
J Stem Cells; 2012; 7(4):211-28. PubMed ID: 24196797
[TBL] [Abstract][Full Text] [Related]
13. Animal models to study adult stem cell-derived, in vitro-generated islet implantation.
Peck AB; Yin L; Ramiya V
ILAR J; 2004; 45(3):259-67. PubMed ID: 15229373
[TBL] [Abstract][Full Text] [Related]
14. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.
Bose B; Katikireddy KR; Shenoy PS
Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920
[TBL] [Abstract][Full Text] [Related]
15. Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation.
Ho BX; Teo AKK; Ng NHJ
Front Immunol; 2024; 15():1375177. PubMed ID: 38650946
[TBL] [Abstract][Full Text] [Related]
16. Cell therapies for pancreatic beta-cell replenishment.
Okere B; Lucaccioni L; Dominici M; Iughetti L
Ital J Pediatr; 2016 Jul; 42(1):62. PubMed ID: 27400873
[TBL] [Abstract][Full Text] [Related]
17. Stem cells to replace or regenerate the diabetic pancreas: Huge potential & existing hurdles.
Bhartiya D
Indian J Med Res; 2016 Mar; 143(3):267-74. PubMed ID: 27241638
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Differentiation of Stem Cell-derived Human Pancreatic Progenitors to Treat Type 1 Diabetes.
Maloy MH; Ferrer MA; Parashurama N
Stem Cell Rev Rep; 2020 Dec; 16(6):1139-1155. PubMed ID: 32844324
[TBL] [Abstract][Full Text] [Related]
19. Xenoislets: porcine pancreatic islets for the treatment of type I diabetes.
Mourad NI; Gianello PR
Curr Opin Organ Transplant; 2017 Dec; 22(6):529-534. PubMed ID: 28915137
[TBL] [Abstract][Full Text] [Related]
20. Generating β-cells in vitro: progress towards a Holy Grail.
Fryer BH; Rezania A; Zimmerman MC
Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):112-7. PubMed ID: 23426161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
